Talk:Tolperisone
| This is the talk page for discussing improvements to the Tolperisone article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tolperisone.
|
comparativ study with thiocolcicoside edit
if any comparative study availabe please inform. —Preceding unsigned comment added by 115.117.157.182 (talk) 17:59, 3 February 2010 (UTC)
more information about tolperisone edit
http://www.japi.org/february_2010/Article_17.pdf ... half-life of tolperisone is 1,5 - 2,5 hours. — Preceding unsigned comment added by 178.235.75.252 (talk) 10:45, 4 August 2013 (UTC)
Interactions grossly understated edit
From the patient information leaflet (last revised: February/March 2013) of the Cypriot distributor (M. K. Stavrinos), section “warnings and precautions:”
Hypersensitivity reactions range from mild skin reactions to severe systemic reactions (e.g. allergic shock). The following groups have a higher risk of experiencing hypersensitivity reactions: women, patients of older age, and patients treated with other medication concurrently (mainly with NSAIDs), patients with drug allergy or allergic diseases or conditions (such as atopy: hay fever, asthma, atopic dermatitis with high serum IgE, urticaria) in the past history, and finally patients who suffer from viral infections during the course of the tolperisone treatment. Early signs of hypersensitivity include flushing, rush, severe itching of the skin, wheezing, difficulty breathing (with or without swelling of the face, lips, tongue, and/or throat), difficulty in swallowing, fast heartbeat, low blood pressure, fast decrease in blood pressure.
Note: This is not a direct quote from the leaflet. I can upload an image of the leaflet upon request.
Can someone with the necessary knowledge edit the interactions section please?
62.195.45.181 (talk) 17:35, 4 March 2016 (UTC)